| Symbol | Company | Weighting |
|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 2.64% |
| EXAS | EXACT SCIENCES CORP | 2.36% |
| FULC | FULCRUM THERAPEUTICS, INC. | 2.33% |
| TSHA | TAYSHA GENE THERAPIES I | 2.17% |
| EYPT | EYEPOINT INC | 2.14% |
| KRRO | KORRO BIO | 2.10% |
| SPRY | ARS PHARMACEUTICALS | 1.93% |
| AVTX | AVALO THERAPEUTICS INC | 1.91% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.90% |
| ICLR | ICON PLC | 1.81% |
| RVMD | REVOLUTION MEDICINES INC | 1.80% |
| ARQT | ARCUTIS BIOTHERAPEUTICS | 1.80% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.79% |
| TNDM | TANDEM DIABETES CARE INC | 1.78% |
| NEO | NEOGENOMICS INC | 1.77% |
| IONS | IONIS PHARMACEUTICALS INC | 1.76% |
| HUM | HUMANA INC | 1.73% |
| BMY | BRISTOL MYERS SQUIBB CO | 1.73% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.70% |
| XENE | XENON PHARMACEUTICALS | 1.68% |
| BRKR | BRUKER CORP | 1.68% |
| RVTY | REVVITY INC | 1.68% |
| MRK | MERCK & CO. NEW | 1.67% |
| PRQR | PROQR THERAPEUTICS NV | 1.67% |
| AXSM | AXSOME THERAPEUTICS INC. | 1.65% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.65% |
| ELV | ELEVANCE HEALTH INC | 1.64% |
| OCS | OCULIS HOLDING AG | 1.64% |
| MDT | MEDTRONIC PLC | 1.62% |
| SLNO | SOLENO THERAPEUTICS INC | 1.62% |
| EWTX | EDGEWISE THERAPEUTICS | 1.61% |
| RGEN | REPLIGEN CORP | 1.60% |
| DNLI | DENALI THERAPEUTICS INC. | 1.60% |
| WAT | WATERS CORP | 1.59% |
| DYN | DYNE THERAPEUTICS, INC. | 1.59% |
| IRON | DISC MEDICINE INC | 1.58% |
| ALC | ALCON INC | 1.57% |
| DHR | DANAHER CORP | 1.57% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.57% |
| UNH | UNITEDHEALTH GROUP INC | 1.57% |
| THC | TENET HEALTHCARE CORP | 1.56% |
| HCA | HCA HOLDINGS INC | 1.56% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.56% |
| AZN | ASTRAZENECA PLC-ADR | 1.54% |
| ZTS | ZOETIS INC | 1.54% |
| CDTX | CIDARA THERAPEUTICS INC | 1.53% |
| ALKS | ALKERMES INC | 1.52% |
| ABT | ABBOTT LABORATORIES | 1.51% |
| MCK | MCKESSON CORP | 1.48% |
| ISRG | INTUITIVE SURGICAL INC | 1.48% |
| SYK | STRYKER CORP | 1.46% |
| SNY | SANOFI- AVENTIS- ADR | 1.45% |
| ABBV | ABBVIE INC | 1.44% |
| VCEL | VERICEL CORP | 1.43% |
| URGN | UROGEN PHARMA LTD. | 1.42% |
| PCVX | VAXCYTE INC | 1.40% |
| LLY | ELI LILLY CORP | 1.40% |
| BSX | BOSTON SCIENTIFIC | 1.37% |
| PODD | INSULET CORP | 1.35% |
| JANX | JANUX THERAPEUTICS INC | 0.81% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.